San Mateo County Logo
Share to Facebook Share to Twitter Bookmark and Share
File #: 22-107    Version: 1 Name:
Type: Resolution Status: Passed
File created: 12/31/2021 Departments: HEALTH
On agenda: 2/8/2022 Final action: 2/8/2022
Title: Adopt a resolution authorizing an agreement with Pear Therapeutics (US), Inc. for the Pear Digital Therapeutic application, for the term of February 1, 2022 through June 30, 2023, in an amount not to exceed $382,950.
Attachments: 1. 20220208_r_Pear Therapeutics, 2. 20220208_a_Pear Therapeutics
Special Notice / Hearing: None__
Vote Required: Majority

To: Honorable Board of Supervisors
From: Louise F. Rogers, Chief, San Mateo County Health
Scott Gilman, Director, Behavioral Health and Recovery Services
Subject: Agreement with Pear Therapeutics (US), Inc.

RECOMMENDATION:
title
Adopt a resolution authorizing an agreement with Pear Therapeutics (US), Inc. for the Pear Digital Therapeutic application, for the term of February 1, 2022 through June 30, 2023, in an amount not to exceed $382,950.

body
BACKGROUND:
In August 2021, Pear Therapeutics (US), Inc. submitted a proposal for a prescription digital therapeutics (PDT) application with San Mateo County Behavioral Health and Recovery Services (BHRS). Through the PDT, this pilot is designed to treat individuals with a substance use disorder (SUD), including opioid use disorders (OUD), with their recovery. This new and innovative service is not yet offered in San Mateo County.

On November 15, 2021, the California Department of Health Care Services awarded San Mateo County an additional $2,200,000 in funding as part of its Substance Abuse Prevention and Treatment Block Grant (SABG). Through this additional funding, BHRS will have the ability to provide innovative SUD prevention and treatment services to San Mateo County residents, and supplement existing SUD prevention and treatment services.

DISCUSSION:
The National Surveys and U.S. Surgeon General reported approximately 90% of individuals diagnosed with a SUD do not seek treatment. For some, access to care is limited due to work, transportation, or childcare needs. Pear Therapeutics (US), Inc. provides the only Food and Drug Administration approved application-based digital therapeutics SUD treatment that can be accessed 24/7 from a smart phone. Clients with a SUD who are otherwise unable to attend traditional outpatient or residential SUD treatment can download the application and engage in a curriculum of evidenced-based Cog...

Click here for full text